Edwards Lifesciences Return on Tangible Equity 2010-2024 | EW
Current and historical return on tangible equity values for Edwards Lifesciences (EW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Edwards Lifesciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $4.16B | $7.05B | 70.35% |
| 2024-06-30 | $1.47B | $5.94B | 27.28% |
| 2024-03-31 | $1.41B | $5.49B | 27.76% |
| 2023-12-31 | $1.40B | $5.18B | 29.23% |
| 2023-09-30 | $1.43B | $5.00B | 31.14% |
| 2023-06-30 | $1.39B | $4.72B | 30.59% |
| 2023-03-31 | $1.49B | $4.31B | 33.24% |
| 2022-12-31 | $1.52B | $4.36B | 33.89% |
| 2022-09-30 | $1.46B | $4.79B | 32.51% |
| 2022-06-30 | $1.46B | $4.46B | 33.83% |
| 2022-03-31 | $1.54B | $4.36B | 37.58% |
| 2021-12-31 | $1.50B | $4.34B | 39.60% |
| 2021-09-30 | $1.48B | $4.05B | 42.51% |
| 2021-06-30 | $1.46B | $3.64B | 46.56% |
| 2021-03-31 | $0.85B | $3.16B | 30.20% |
| 2020-12-31 | $0.82B | $3.07B | 31.34% |
| 2020-09-30 | $0.79B | $2.71B | 31.48% |
| 2020-06-30 | $0.74B | $2.34B | 30.81% |
| 2020-03-31 | $1.11B | $2.40B | 47.85% |
| 2019-12-31 | $1.05B | $2.64B | 47.24% |
| 2019-09-30 | $0.77B | $2.28B | 39.16% |
| 2019-06-30 | $0.73B | $1.94B | 39.19% |
| 2019-03-31 | $0.77B | $2.00B | 43.53% |
| 2018-12-31 | $0.72B | $1.69B | 43.45% |
| 2018-09-30 | $0.71B | $1.77B | 45.03% |
| 2018-06-30 | $0.66B | $1.58B | 41.52% |
| 2018-03-31 | $0.56B | $1.62B | 35.47% |
| 2017-12-31 | $0.58B | $1.36B | 38.29% |
| 2017-09-30 | $0.75B | $1.77B | 45.73% |
| 2017-06-30 | $0.72B | $1.57B | 43.37% |
| 2017-03-31 | $0.66B | $1.40B | 39.39% |
| 2016-12-31 | $0.57B | $1.79B | 33.82% |
| 2016-09-30 | $0.55B | $1.86B | 33.34% |
| 2016-06-30 | $0.53B | $1.63B | 33.27% |
| 2016-03-31 | $0.52B | $1.47B | 31.09% |
| 2015-12-31 | $0.50B | $1.67B | 28.34% |
| 2015-09-30 | $0.46B | $1.59B | 26.05% |
| 2015-06-30 | $0.44B | $1.90B | 24.60% |
| 2015-03-31 | $0.87B | $1.83B | 51.74% |
| 2014-12-31 | $0.81B | $1.79B | 55.40% |
| 2014-09-30 | $0.78B | $1.64B | 59.88% |
| 2014-06-30 | $0.76B | $1.50B | 66.84% |
| 2014-03-31 | $0.31B | $0.92B | 29.22% |
| 2013-12-31 | $0.39B | $1.13B | 35.39% |
| 2013-09-30 | $0.40B | $0.99B | 37.50% |
| 2013-06-30 | $0.40B | $1.13B | 35.63% |
| 2013-03-31 | $0.37B | $1.15B | 34.23% |
| 2012-12-31 | $0.29B | $1.03B | 28.03% |
| 2012-09-30 | $0.27B | $1.13B | 26.20% |
| 2012-06-30 | $0.25B | $1.02B | 25.74% |
| 2012-03-31 | $0.24B | $0.98B | 25.10% |
| 2011-12-31 | $0.24B | $0.92B | 25.28% |
| 2011-09-30 | $0.24B | $0.94B | 25.46% |
| 2011-06-30 | $0.24B | $0.96B | 25.63% |
| 2011-03-31 | $0.24B | $0.93B | 27.38% |
| 2010-12-31 | $0.22B | $0.93B | 26.92% |
| 2010-09-30 | $0.20B | $0.85B | 26.20% |
| 2010-06-30 | $0.23B | $0.73B | 31.22% |
| 2010-03-31 | $0.22B | $0.75B | 31.27% |
| 2009-12-31 | $0.23B | $0.76B | 35.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.156B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |